Fraunhofer-Gesellschaft

Publica

Hier finden Sie wissenschaftliche Publikationen aus den Fraunhofer-Instituten.

Continuous adenosine A(2A) receptor antagonism after focal cerebral ischemia in spontaneously hypertensive rats

 
: Fronz, Ulrike; Deten, Alexander; Baumann, Frank; Kranz, Alexander; Weidlich, Sarah; Härtig, Wolfgang; Nieber, Karen; Boltze, Johannes; Wagner, Daniel-Christoph

:

Naunyn-Schmiedebergs archives of pharmacology 387 (2014), Nr.2, S.165-173
ISSN: 0028-1298
ISSN: 1432-1912
Englisch
Zeitschriftenaufsatz
Fraunhofer IZI ()
brain ischemia; stroke; SHR rat; adenosine A2A receptor; 8-CSC

Abstract
Antagonism of the adenosine A(2A) receptor (A(2A)R) has been shown to elicit substantial neuroprotective properties when given immediately after cerebral ischemia. We asked whether the continuous application of a selective A(2A)R antagonist within a clinically relevant time window will be a feasible and effective approach to treat focal cerebral ischemia. To answer this question, we subjected 20 male spontaneously hypertensive rats to permanent middle cerebral artery occlusion and randomized them equally to a verum and a control group. Two hours after stroke onset, the animals received a subcutaneous implantation of an osmotic minipump filled with 5 mg kg(-1) day(-1) 8-(3-chlorostyryl) caffeine (CSC) or vehicle solution. The serum level of CSC was measured twice a day for three consecutive days. The infarct volume was determined at days 1 and 3 using magnetic resonance imaging. We found the serum level of CSC showing a bell-shaped curve with its maximum at 36 h. The infarct volume was not affected by continuous CSC treatment. These results suggest that delayed and continuous CSC application was not sufficient to treat acute ischemic stroke, potentially due to unfavorable hepatic elimination and metabolization of the pharmaceutical.

: http://publica.fraunhofer.de/dokumente/N-281968.html